Big Pharma vs. RUO Look, I’ve always been a huge supporter of the grey market and will always be. Big pharma can keep their $1,200/month pens and their gatekeeping. A lot of us got results they never would’ve let us have, and I’m not about to pretend otherwise. That said, the heat is real right now and not everyone is gonna make it. The ones who only had the basic injectable GLP menu and nothing else are getting squeezed hard. The survivors are gonna be the shops that actually adapting either by getting creative with how they structure and present their offerings (or hide them rather), or by moving past solely injectables altogether. Anyone still touching actual Tirz or Reta is gonna have to play it smarter. That means burying them behind more complex structures, multi-step processes, or just quietly shifting into the other solid fat-loss compounds and the GLP-adjacent molecules that are essentially doing the same job without being literal Tirz or Reta. Some of those copycats are close enough that most people won’t care, and likely will be very effective, until their also in the same scrutiny, then its on to the next one.. On top of that, manufacturing is getting shut down left and right in China on the Lilly GLPs. This isn’t the usual fear-mongering we’ve seen with other compounds over the years. This one is legit, and it’s gonna make getting the real thing an actual problem. Reta is getting hit the hardest of all. A lot of the pipelines that were quietly supplying it are drying up fast, and the ones left are getting nervous. Im still not quite to the “bulk" stock-up point, because I still think new and better is always likely, BUT if there was one time, we are near it if some want too. The top players in this space already see it. They’ve got the relationships, the testing habits, and the willingness to move. Those are the ones who are still gonna be around once the current wave of pressure settles. Everyone else is just hoping they don’t get noticed. That’s my take. The grey market isn’t dying, it’s just getting pickier about who sticks around.

Why Nattokinase is the one supplement almost every TRT & AAS user Is still underdosing Nattokinase is one of the first supplements the bro community tells you to grab when you hop on TRT. Most guys either buy the standard 2,000 FU bottle and call it a day, or they take it without actually understanding what it does. Either way, they’re usually leaving the real benefits on the table. It’s even more relevant if you’re enhanced. AAS push the same blood-thickening effects as TRT (higher hematocrit and viscosity aren’t inherently bad-that’s part of how androgens work), but they raise the stakes on clotting risk and cardiovascular strain. Nattokinase is one of the cheapest, most practical tools you can add to keep blood moving better while you’re on. I run around 10,000 FU a day and have for years. What it actually is Nattokinase is an enzyme produced when Bacillus subtilis ferments soybeans into natto. It’s a serine protease with strong fibrinolytic activity, meaning it helps break down fibrin, the protein mesh that holds blood clots together. It’s measured in fibrinolytic units (FU), not milligrams. A 100 mg capsule can be 2,000 FU or far less depending on potency, so always check the FU number. How it works It works through multiple mechanisms: -Directly degrades fibrin. -Boosts tissue plasminogen activator (tPA) activity and inhibits PAI-1 (the main brake on the body’s own clot-dissolving system). -Lowers clotting factors VII and VIII. -Reduces red blood cell aggregation and whole-blood viscosity. The net effect is better blood fluidity and less fibrin buildup without acting like a pharmaceutical anticoagulant. Why it matters on TRT and AAS Testosterone and other androgens stimulate red blood cell production. Hematocrit rises, blood gets thicker, and the risk of micro-clots or higher cardiac workload goes up. Nattokinase doesn’t reliably lower hematocrit the way phlebotomy or dose adjustments do, don’t treat it as a replacement for managing high HCT properly, but it supports the fibrinolysis side of the equation and helps keep blood from getting sticky. That matters more the higher your dose and the longer you’re on. Beyond that, the data shows broader cardiovascular support. A large 12-month clinical study using 10,800 FU/day reported roughly 36% reduction in carotid plaque area, about 22% reduction in carotid intima-media thickness, and solid lipid shifts (LDL down ~18%, HDL up ~16%). The same study found 3,600 FU/day did essentially nothing for those markers. Smaller trials show modest blood pressure reductions at lower doses (around 2,000 FU). Most commercial products are dosed at 2,000 FU because that’s the amount used in the early blood pressure studies and what the Japanese Nattokinase Association recommends as a baseline. For the stronger effects seen on plaque and lipids, the higher end (closer to 6,000-10,800 FU) is what the data points to. Take it on an empty stomach for better absorption. Look for products standardized to FU, preferably third-party tested for activity. It’s generally well-tolerated at the doses studied (including 10,800 FU), but it has real fibrinolytic activity, so don’t stack it with prescription anticoagulants or antiplatelets as much if you can truly avoid it. This gives you a cheap, evidence-backed edge on the clotting and viscosity side of the equation that androgens create. For the price, it’s one of the higher-leverage additions to a TRT or enhanced protocol. Most people just underdose it.